ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Employment and Work Disability"

  • Abstract Number: 3056 • ACR/ARHP Annual Meeting 2016

    Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Randomized Controlled Trial

    Julie J. Keysor1,2, Michael P. LaValley3, Carrie Brown4, David T. Felson5, Rawan AlHeresh6, Molly Vaughan7, Robert A. Yood8, John Reed9 and Saralynn Allaire10, 1Physical Therapy, Boston University, Boston, MA, 2Clinical Epidemiology Research and Training, Boston University School of Medicine, Boston, MA, 3Biostatistics, Boston University School of Public Health, Boston, MA, 4Boston University School of Public Health, Boston, MA, 5Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 6Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, 7635 Commonwealth Avenue, Room 651, Boston University College of Health & Rehabilitation Sciences, Boston, MA, 8Fallon Clinic, Worcester, MA, 9Rheumatology, Reliant Medical Group, Worcester, MA, 10Clinical Epidemiology Research and Training Unit, Clinical Epidemiology, BUSM, Boston, MA

    Background/Purpose: Rheumatic and musculoskeletal conditions are leading causes of work disability. A previous trial showed a preventive work disability intervention delivered by vocational rehabilitation counselors…
  • Abstract Number: 449 • ACR/ARHP Annual Meeting 2013

    Work Instability In Early Rheumatoid Arthritis With Elevated Risk Of Employment Loss: Effects Of Adalimumab/Methotrexate Combination Therapy Versus Methotrexate In a Randomized Clinical Trial

    Arthur Kavanaugh1, Josef S. Smolen2, Arijit Ganguli3, Hartmut Kupper3, Mary Cifaldi3, Naijun Chen3 and Dennis Revicki4, 1University of California, San Diego, La Jolla, CA, 2Medical University of Vienna, Vienna, Austria, 3AbbVie Inc., North Chicago, IL, 4United BioSource, Bethesda, MD

    Background/Purpose: Intensive treatment of early rheumatoid arthritis (RA) has been shown to reduce functional disability over time and to positively impact employment outcomes. Adalimumab (ADA)…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology